Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
Clinical-stage biopharma company Mind Medicine (MindMed), Inc. (NASDAQ: MNMD) shared its financial results for the full year ended Dec. 31, 2022.
Numbers show solid stability:
EF Hutton Reiterates Buy on Mind Medicine, Maintains $21 Price Target
EF Hutton analyst Elemer Piros reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $21 price target.
‘Oklahoma House Approves Psilocybin Bill Protecting Patients From Prosecution And Promoting Research’ – Marijuana Moment
https://www.marijuanamoment.net/oklahoma-house-approves-psilocybin-bill-protecting-patients-from-prosecution-and-promoting-research/
The Oklahoma House of Representatives has approved a bill to promote research into the
‘Hawaii Senate Approves Marijuana Legalization And Psychedelic Research Bills’ – Marijuana Moment
https://www.marijuanamoment.net/hawaii-senate-approves-marijuana-legalization-and-psychedelic-research-bills/
Here Are The Year’s Highest Priced Psychedelics Stocks In US Markets
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
‘Hawaii Senators Approve Bill To Promote Research Into Psilocybin And MDMA Therapy’ – Marijuana Moment
https://www.marijuanamoment.net/hawaii-senators-approve-bill-to-promote-research-into-psilocybin-and-mdma-therapy/
Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of
‘Hawaii Senate Committee Approves Bill To Create Therapeutic Psilocybin Working Group’ -Marijuana Moment Report
https://www.marijuanamoment.net/hawaii-senate-committee-approves-bill-to-create-therapeutic-psilocybin-working-group/
‘Change To Classification Of Psilocybin And MDMA To Enable Prescribing By Authorized Psychiatrists’; Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change – Australian Government Department Of Health And Aged Care
https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA
‘Psychedelics Bills Filed In Four More States As 2023 Reform Efforts Heat Up’ -Marijuana Moment Report
https://www.marijuanamoment.net/psychedelics-bills-filed-in-four-more-states-as-2023-reform-efforts-heat-up/